Graypoint LLC’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,771
| Closed | -$225K | – | 549 |
|
|
2025
Q1 | $225K | Buy |
2,771
+1
| +0% | +$81 | 0.01% | 473 |
|
|
2024
Q4 | $250K | Buy |
2,770
+32
| +1% | +$2.88K | 0.02% | 444 |
|
|
2024
Q3 | $271K | Buy |
2,738
+146
| +6% | +$14.4K | 0.02% | 420 |
|
|
2024
Q2 | $240K | Buy |
2,592
+22
| +0.9% | +$2.04K | 0.02% | 423 |
|
|
2024
Q1 | $244K | Buy |
+2,570
| New | +$244K | 0.02% | 408 |
|
|
2023
Q3 | – | Sell |
-3,589
| Closed | -$299K | – | 429 |
|
|
2023
Q2 | $299K | Buy |
3,589
+142
| +4% | +$11.8K | 0.03% | 309 |
|
|
2023
Q1 | $263K | Buy |
3,447
+231
| +7% | +$17.6K | 0.03% | 303 |
|
|
2022
Q4 | $267K | Buy |
3,216
+79
| +3% | +$6.56K | 0.03% | 286 |
|
|
2022
Q3 | $249K | Buy |
3,137
+58
| +2% | +$4.6K | 0.03% | 281 |
|
|
2022
Q2 | $229K | Sell |
3,079
-100
| -3% | -$7.44K | 0.03% | 268 |
|
|
2022
Q1 | $286K | Buy |
+3,179
| New | +$286K | 0.03% | 270 |
|